Health

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study

Currax Pharmaceuticals LLC (“Currax”) today announced top-line results from a Cardiovascular Health Outcomes Analysis (HOA). This study evaluated the cardiovascular safety of CONTRAVE®/MYSIMBA®, a weight management drug. The real-world study compared CONTRAVE®/MYSIMBA® to a similar product for the purpose of measuring major adverse cardiovascular events (MACE). The primary analysis included over 24,600 patients with an average…

thaipr.net

19 ต.ค. 66

SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement

SHL Medical (“SHL”), a world-leading solutions provider of advanced drug delivery systems such as autoinjectors and innovative specialty delivery systems, has entered into a non-exclusive co-marketing partnership agreement with Lifecore Biomedical (Nasdaq: LFCR) (“Lifecore”), a fully integrated Contract Development and Manufacturing Organization (“CDMO”) that offers highly differentiated capabilities in the…

thaipr.net

18 ต.ค. 66

Bridging the Healthcare Gap in Thailand and Beyond with the Belt and Road Initiative

“I have a dream that everyone should have the ability to access medical care equally,” says Oraphan Wanacharoen (Ice), BGI Genomics Field Application Scientist. “It’s very challenging to achieve such a goal in Thailand. With the advanced technology of the company and our sustained development, I believe that we will be able to realize this dream.” […]

thaipr.net

18 ต.ค. 66

UEG Week 2023 : Babies with a low birthweight four times more likely to develop fatty liver disease in later life

A groundbreaking new study, presented today at UEG Week 2023, has discovered a significant connection between birthweight and the onset of nonalcoholic fatty liver disease, now known as metabolic dysfunction-associated steatotic liver disease (MASLD), in young people. Notably, babies with a low birthweight were found to be four times more likely to develop MASLD in […]

thaipr.net

16 ต.ค. 66

LifeSpan Vision Ventures Makes 7th Investment in Pursuit of Longevity Mission

LifeSpan Vision Ventures, a venture capital firm dedicated to advancing the field of longevity biotech, is proud to announce the closing of its seventh investment, marking another significant step towards its mission of extending healthspan. The newest addition to LifeSpan’s portfolio is Rejuvenation Technologies, who use lipid nanoparticles to deliver telomerase mRNA to restore telomere […]

thaipr.net

16 ต.ค. 66

World Health Summit kicks off in Berlin

Experts from around the world meet at the most important forum on global health The World Health Summit 2023, the world’s leading meeting for global health, began Sunday morning in Berlin. From October 15 to 17, international representatives from politics, science, business and civil society will discuss crucial issues in global health under the motto […]

thaipr.net

16 ต.ค. 66
1 … 25 26 27 28 29 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.